Archana Singh-Manoux
  • E-mail :[email]
  • Phone : 01 57 27 90 41
  • Location : Paris, France
Last update 2019-06-26 11:50:50.084

Archana Singh-Manoux PhD, HDR Epidemiology

Course and current status


  • Research Professor (DR1), INSERM
  • Honorary Professor, University College London



  • 2018: Prix Coups d'élan, Fondation Bettencourt Schueller
  • 2015: Prix Recherche Inserm
  • 2010: Member, Academia Europaea, The Academy of Europe
  • 2005: Chair of Excellence Award: French Ministry of Research
  • 2005: ERC Starting Grant


H-index: 60 (Web of Science), 64 (Scopus), 85 (Google Scholar)

Top 1% highly cited scientist 2017, 2018

10 KEY PUBLICATIONS (out of a total >325)

  1. Kivimäki M, Singh-Manoux A. Prevention of dementia by targeting risk factors. Lancet. 2018; 391(10130):1574-1575
  2. Sabia S, Fayosse A, Dumurgier J, Dugravot A, Akbaraly T, Britton A, Kivimäki M, Singh-Manoux A. Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study. BMJ. 2018;362:k2927.
  3. Singh-Manoux A, Fayosse A, Sabia S, Tabak A, Shipley M, Dugravot A, Kivimäki M. Clinical, socioeconomic, and behavioural factors at age 50 years and risk of cardiometabolic multimorbidity and mortality: A cohort study. PLoS Med. 2018; 15(5):e1002571. doi: 10.1371/journal.pmed.1002571
  4. Abell JG, Kivimäki M, Dugravot A, Tabak AG, Fayosse A, Shipley M, Sabia S, Singh-Manoux A. Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension. Eur Heart J. 2018;39(33):3119-3125.
  5. Singh-Manoux A, Dugravot A, Shipley M, Brunner EJ, Elbaz A, Sabia S, Kivimaki M. Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study.  Alzheimers Dement. 2018; 14(2): 178-186.
  6. Singh-Manoux A, Dugravot A, Fournier A, Abell J, Ebmeier K, Kivimäki M, Sabia S. Trajectories of Depressive Symptoms Before Diagnosis of Dementia: A 28-Year Follow-up Study. JAMA Psychiatry. 2017; 74: 712-718.
  7. Singh-Manoux A, Fayosse A, Sabia S, Canonico M, Bobak M, Elbaz A, Kivimäki M, Dugravot A. Atrial fibrillation as a risk factor for cognitive decline and dementia. Eur Heart J. 2017;38(34):2612-2618.
  8. Rusmaully J, Dugravot A, Moatti JP, Marmot MG, Elbaz A, Kivimaki M, Sabia S, Singh-Manoux A. Contribution of cognitive performance and cognitive decline to associations between socioeconomic factors and dementia: A cohort study. PLoS Med. 2017; 14(6):e1002334.
  9. Sabia S, Dugravot A, Dartigues JF, Abell J, Elbaz A, Kivimäki M, Singh-Manoux A. Physical activity, cognitive decline, and risk of dementia: 28 year follow-up of Whitehall II cohort study. BMJ. 2017; 357:j2709.
  10. Tuligenga RH, Dugravot A, Tabák AG, Elbaz A, Brunner EJ, Kivimäki M, Singh-Manoux A. Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet Diabetes Endocrinol. 2014; 2: 228-35.



  • 2015 onwards: Board of Directors, Fondation Plan Alzheimer, France.
  • 2015 onwards: Scientific Council, Fondation Recherche Medicale, France.
  • 2011-2014: Deputy Director, French Institute of Public Health (ITMO-Santé Publique)
  • 2011 onwards: Associate Editor, Journal of Epidemiology & Community Health.


RESEARCH GRANTS (a selection)

  • 2018-2023: Principal Investigator on grant R01AG056477 (Education, socioeconomic status and Aging: transitions from multimorbidity to functional limitations and mortality) from the National Institute on Aging, NIH, USA
  • 2018-2023: Co-Investigator on Grant MR/R024227 (The Whitehall II study: A Core Resource for Ageing Research) from the Medical Research Council, MRC
  • 2017-2019: : Principal Investigator on grant R56AG056477 (Education and Aging: transitions from multimorbidity to functional limitations) from the National Institute on Aging, NIH, USA
  • 2017-2021: Co-Investigator on Grant, “Vascular risk and functional decline in old age: from discovery to translation”. RG/16/11/32334, British Heart Foundation.

Scientific summary

Epidemiology of Ageing and Neurodegenerative diseases (Team EpiAgeing, CRESS), Inserm U1153, Paris.

Whitehall II study, University College London,

My research is on the determinants of cognitive decline and dementia with a focus on socioeconomic, occupational, psychosocial, behavioural and biological factors. A second aspect of my work is on the social determinants of health at older ages in order to understand the mechanisms underlying inequalities in health.

Image d’exemple